A CLINICAL EVALUATION OF HYPERKALAEMIA IN PATIENTS WITH RENAL IMPAIRMENT ON COMBINATION THERAPY OF ANGIOTENSIN-CONVERTING ENZYME INHIBITOR AND ANGIOTENSIN-RECEPTOR BLOCKER

被引：0
|
作者：
Goh, T. H. [1 ]
Tan, S. C. [1 ]
Fook-Chong, S. M. C. [1 ]
Wong, K. S. [1 ]
Chan, C. M. [1 ]
机构：
[1] Singapore Gen Hosp, Singapore, Singapore
来源：
NEPHROLOGY | 2005年 / 10卷
关键词：
D O I：
暂无
中图分类号：
R5 [内科学]; R69 [泌尿科学（泌尿生殖系疾病）];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：A139 / A139
页数：1
相关论文
共 50 条
  • [21] Advantages of combination therapy of hypertension with calcium channel blocker and angiotensin-converting enzyme inhibitor in patients with impaired renal function
    Dzhaiani, N. A.
    RATIONAL PHARMACOTHERAPY IN CARDIOLOGY, 2014, 10 (02) : 238 - 244
  • [22] Cough in Pediatric Patients Receiving Angiotensin-Converting Enzyme Inhibitor Therapy or Angiotensin Receptor Blocker Therapy in Randomized Controlled Trials
    Baker-Smith, C. M.
    Benjamin, D. K., Jr.
    Califf, R. M.
    Murphy, M. D.
    Li, J. S.
    Smith, P. B.
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2010, 87 (06) : 668 - 671
  • [23] Clinical evidence from ONTARGET: the value of an angiotensin II receptor blocker and an angiotensin-converting enzyme inhibitor
    Sleight, Peter
    JOURNAL OF HYPERTENSION, 2009, 27 : S23 - S29
  • [24] Efficacy of combination therapy with angiotensin-converting enzyme inhibitor and calcium channel blocker in hypertension
    Redon, Josep
    Trenkwalder, Peter R. A.
    Barrios, Vivencio
    EXPERT OPINION ON PHARMACOTHERAPY, 2013, 14 (02) : 155 - 164
  • [25] Combination therapy with angiotensin-converting enzyme inhibitor and angiotensin receptor blocker with early statin administration in patients admitted to a coronary unit for unstable angina
    Gabrielyan, R. S.
    Davtyan, A. V.
    Gabrielyan, A.
    EUROPEAN HEART JOURNAL, 2005, 26 : 567 - 567
  • [26] Optimal dose of angiotensin-converting enzyme inhibitor or angiotensin II receptor blocker for renoprotection
    Hou, Fan Fan
    Zhou, Qiu Gen
    NEPHROLOGY, 2010, 15 : 57 - 60
  • [27] The effects of angiotensin-converting enzyme inhibitor, angiotensin receptor blocker, and it's combination therapies on development of diabetic nephropathy
    Sen, Saniye
    Ustundag, Sedat
    Gonlusen, Gulfiliz
    Kanter, Mehmet
    Dogutan, Haluk
    Ciftci, Senturk
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 2006, 21 : 53 - 53
  • [28] Angiotensin-Converting Enzyme Inhibitor, Angiotensin Receptor Blocker Use, and Mortality in Patients With Chronic Kidney Disease
    Molnar, Miklos Z.
    Kalantar-Zadeh, Kamyar
    Lott, Evan H.
    Lu, Jun Ling
    Malakauskas, Sandra M.
    Ma, Jennie Z.
    Quarles, Darryl L.
    Kovesdy, Csaba P.
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2014, 63 (07) : 650 - 658
  • [29] Angiotensin-converting enzyme inhibitors, angiotensin-receptor blockers, and risk of appendicitis
    Mukamal, Kenneth J.
    Ghimire, Sanjay
    Pandey, Rudra
    Fiarman, Gale S.
    Gautam, Shiva
    ANNALS OF EPIDEMIOLOGY, 2012, 22 (10) : 747 - 750
  • [30] Uncritical Acceptance of Combination Treatment of Angiotensin II Receptor Blocker and Angiotensin-Converting Enzyme Inhibitor in Nondiabetic Renal Disease Trial Results
    Griffin, Karen A.
    Bidani, Anil K.
    HYPERTENSION, 2009, 53 (01) : E3 - E3
12345